Acute Porphyria Drug Database

Monograph

L01DA01 - Dactinomycin
Not porphyrinogenic
NP

Rationale
Undergoes only minimal metabolism, insignificant hepatic exposure. Side effects such as nausea and vomiting may be potentially porphyrinogenic through reduction in caloric intake.
Chemical description
Highly toxic antibiotic isolated from Streptomyces parvulus.
Therapeutic characteristics
Dactinomycin is used in the tratment of Wilms tumor, gesatational trophoblastic tumors, nonseminomatous testicular cancer, sarcomas such as rhabdomyosarcoma and Ewings sarcoma. Administered as an intravenous infusion. Common adverse reactions of dactinmycin that can be confused with an acute porphyric attack are vomiting, abdominal pain and nausea. Side effects such as nausea, anorexia and vomiting may be potentially porphyrinogenic through reduction in caloric intake.
Hepatic exposure
Insignificant.
Metabolism and pharmacokinetics
Dactinmycin undergoes minimal metabolism. Slowly excreted mainly in unchaged form in urine and bile.
Published experience
Uneventful use reported in male AIP patient with testicular cancer (Arbus et al, 1981).
IPNet drug reports
No.

References

# Citation details PMID
*Scientific articles
1. Relationship between porphyria and the use of antineoplastics.
Arbus MH. Am J Hosp Pharm. 1981;38(5):631.
7282689
*Drug reference publications
2. McEvoy GK, editor. Dactinomycin. The AHFS Drug Information 2008. Bethesda, MD: American Society of Health-System Pharmacists; 2009. Electronic version (04.05.10).
3. Sweetman SC, editor. Martindale: The complete drug reference. Dactinomycin. Pharmaceutical Press 2009.
*Summary of Product Characteristics
4. Norwegian medicines agency. Summary of Product Characteristics (SPC). Cosmegen.

Similar drugs
Explore alternative drugs in similar therapeutic classes L01D / L01DA or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
United Kingdom
Cosmegen Lyovac ยท Cosmegen Lyovac 500microgram powder for solution for injection vials
Norway
Lyovac-Cosmegen farma mondo
 
© NAPOS 2024
An unhandled error has occurred. Reload ๐Ÿ—™